Notochordal conditioned media from tissue increases proteoglycan accumulation and promotes a healthy nucleus pulposus phenotype in human mesenchymal stem cells
© Purmessur et al.; licensee BioMed Central Ltd. 2011
Received: 14 December 2010
Accepted: 31 May 2011
Published: 31 May 2011
Notochordal cells (NCs) are influential in development of the intervertebral disc (IVD) and species that retain NCs do not degenerate. IVD repair using bone marrow derived mesenchymal stem cells (MSCs) is an attractive approach and the harsh microenvironment of the IVD suggests pre-differentiation is a necessary first step. The goal of this study was to use soluble factors from NCs in alginate and NCs in their native tissue to differentiate human MSCs to a young nucleus pulposus (NP) phenotype.
Human MSCs (cultured under micromass conditions for 21 days in hypoxia) were differentiated with conditioned medium derived from porcine notochordal cells in native tissue (NCT) or in alginate beads (NCA), and compared with chondrogenic (TGFβ-3) or basal medium. A PCR array of 42 genes was utilized to screen a large number of genes known to be associated with the healthy NP phenotype and pellet cultures were also evaluated for glycosaminoglycan content, histology and viability. Proteomic analysis was used to assess candidate soluble factors in NCA and NCT.
Notochordal cell conditioned media had diverse effects on MSC phenotype. NCT resulted in the highest levels of glycosaminoglycan (GAG), as well as up-regulation of SOX9 and Collagen II gene expression. NCA demonstrated effects that were catabolic yet also anti-fibrotic and minimally hypertrophic with down-regulation of Collagens I and III and low levels of Collagen X, respectively. Micromass culture and hypoxic conditions were sufficient to promote chondrogenesis demonstrating that both basal and chondrogenic media produced similar phenotypes. Candidate matricellular proteins, clusterin and tenascin were identified by proteomics in the NCA group.
NCs secreted important soluble factors capable of differentiating MSCs to a NP phenotype synthesizing high levels of proteoglycan while also resisting collagen fiber expression and hypertrophy, yet results were sensitive to the conditions in which media was generated (cells in alginate versus cells in their native tissue) so that further mechanistic studies optimizing culture conditions and defining important NC secreted factors are required. Matricellular proteins, such as clusterin and tenascin, are likely to be important to optimize differentiation of MSCs for maximum GAG production and reduced collagen fiber expression.
Current surgical therapies to treat intervertebral disc (IVD) degeneration include spinal fusion and arthroplasty; these methods are highly invasive and are often associated with reduced patient mobility . Cell based therapies are an attractive alternative since they may be applied in a minimally invasive manner with the ability to address an underlying cause of degeneration. IVD degeneration is associated with increased cell apoptosis and senescence, an up-regulation of pro-inflammatory and pain-related proteins, and ultimately, a breakdown of the disc matrix [2–5]. Cell-based therapies aim to restore metabolic homeostasis within the IVD and reduce inflammation by replacing or augmenting the disc cells at an early stage of degeneration. Such therapies can adapt and integrate with the native tissue microenvironment restoring structure and function with limited long term side effects. One promising cell choice is mesenchymal stem cells (MSCs). MSCs are multipotent cells predominantly found in bone marrow that have the plasticity to differentiate into cells of the chondrocytic, adipogenic and osteogenic lineages . However, there is evidence to suggest that MSCs may not be well suited to the hostile anaerobic environment of the diseased IVD [7, 8] so that long term survival and integration within the disc may require pre-differentiation of the MSCs in culture towards a phenotype more representative of native IVD cells.
There are at least two cell populations in the disc, the fibrochondrocytes that populate and maintain the annulus fibrosus (AF) and the more chondrocytic cells in the nucleus pulposus (NP). The NP cells are often described as being "chondrocyte-like" as a consequence of their morphology and the extracellular matrix proteins they synthesize (such as collagen type II and aggrecan). The glycosaminoglycan (GAG) to hydroxyproline ratio is an important distinguishing characteristic between NP cells with ratios as high as 27:1 and hyaline chondrocytes with ratios as low as 2:1 .
MSCs are a promising potential cell source for IVD repair, as described by a number of in vitro and in vivo studies [10–19]. The interaction between MSCs and cells of the native IVD, including the adaptation of MSCs to the IVD microenvironment, enhanced MSC metabolism and biosynthesis; however, the magnitude of effects appears to be dependent on cell ratio and whether the cell contact is indirect or direct [12, 18–20]. Studies suggest that a ratio of 75% NP:25% MSC with direct cell-cell contact provides the optimal culture conditions for MSC differentiation and matrix expression toward a chondrocyte-like phenotype . This interaction appears to be independent on MSC source, as both autologous and allogenic MSCs interact favorably with NP cells [16, 19]. In vivo, the ability of MSCs to improve biosynthesis and restore homeostasis within degenerated IVD is likely to be dependent on their long term survival in the native IVD microenvironment. Injection of undifferentiated MSCs into the IVDs of small animal models such as degenerated rabbit IVDs depleted of NP tissue demonstrated survival of MSCs for up to 48 weeks . However, the tissue composition (NP matrix) and cell populations (predominantly notochordal NP cells) in these animal models differ radically from those present clinically in human degenerated IVDs.
Differentiation of MSCs toward an NP phenotype is more complex than differentiation towards a hyaline chondrocyte lineage . Differentiation toward an NP phenotype is likely to depend on diverse biological parameters such as an appropriate choice or combination of growth factors, 3D matrix, cell-cell contact and environmental conditions mimicking the IVD such as hypoxia. Further, only very recently, has the phenotype of NP cells become more clearly defined. While no single definitive NP marker exists, many laboratories have examined potential markers associated with a "healthy NP phenotype" in a diverse range of animal species including human IVDs and these studies are ongoing [22–26]. The proteoglycan-rich matrix and high proteoglycan to collagen ratio of the human NP is considered an important marker when determining a healthy NP phenotype . Based on literature a healthy NP like phenotype can be considered as high proteoglycan biosynthesis, increases in the matrix proteins SOX9, collagen II, aggrecan, phenotypic markers such as keratin-19 and transforming growth factors 1 and 3 (TGFβ-1 and -3) [10, 22, 27, 28]. This is coupled with decreases in collagens I, III and X, the catabolic enzymes matrix metalloproteinases (MMPs) and A distintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) and inflammatory cytokines interleukin-1β (IL-1 β) and tumour necrosis factor alpha (TNFα) [2, 4, 29, 30],
The notochord plays an influential role in early development of the IVD  and exposing MSCs to notochordal cells (NCs) has been proposed as a powerful method for differentiation to an NP phenotype . In a number of species, including humans, during growth and aging, the NCs populating the NP disappear and are replaced by chondrocytic NP cells . The NP of some species retain notochord cells into maturity, for example, the pig, rabbit, non-chondrodystrophoid dogs and rodents, and the IVDs of these species do not experience degeneration of the IVD , suggesting an association between NCs with IVD development and maintenance of the healthy NP phenotype. It has previously been shown that NCs, including conditioned medium derived from NCs (NCCM) has enhanced IVD cell and articular chondrocyte metabolism [34, 35]. More recent studies by Korecki et al. have shown that NCCM from porcine NCs seeded in alginate increased GAG production and up-regulated Laminin B1 and collagen type III in human MSCs after seven days in culture . While NCCM demonstrates strong promise for NP differentiation, generation of NCCM was not optimized. For example, Korecki et al. employed NCs isolated from their native tissue environment in order to highlight the relevance of NCs alone. Yet, the cell matrix interactions will influence the production of soluble factors from NCs which maintain the healthy IVD, and it is speculated that generation of NCCM within the native tissue environment has anabolic soluble factors that may improve differentiating potential of MSCs cells to an NP phenotype.
We hypothesize that NCCM generated from NCs in their native tissue environment will trigger differentiation of MSCs toward an NP phenotype to a greater extent than both notochordal media generated from NC cells in alginate and chondrogenic media (TGFβ-3) alone. The first aim of this study was to pre-differentiate MSCs into cells with a healthy NP-phenotype based on custom PCR array analysis and GAG production as defined above. A custom PCR array was designed to evaluate expression of 42 genes chosen from recent literature in order to characterize NP cell phenotype, matrix protein, catabolic/anti-catabolic protein, growth factor and pain/inflammatory protein expression. The second aim was to identify the optimal conditions for generating conditioned media by comparing the effects of CM derived from NCs seeded in alginate or derived from notochordal tissue, as compared with chondrogenic media with TGFβ-3. The last aim consisted of a pilot study of proteomic analysis of secreted protein factors from the NCT and NCA conditioned media that may provide instructive cues and create unique extracellular environments that would contribute to our understanding of how NCs influence development of a healthy NP phenotype.
Materials and methods
Generation of conditioned media from porcine IVD cells and tissue
The average ratio of notochordal to NP cells isolated from the IVDs of each pig spine was 88%:12%, similar to that found by Chen et al. ; therefore, the whole pool of NP cells were taken to be predominantly notochordal in nature. NP tissue was carefully isolated aseptically from IVDs of two- to eight-month-old female porcine spines (n = 8) obtained within 24 hours of death (Animal Facility Research 87 Inc., Boylston, MA, USA). To generate conditioned media (CM) from notochordal cells seeded in alginate beads (NCA), NP tissue was first digested as described by Urban et al. . Briefly, tissue was digested with 0.2% protease (from Streptomyces griseus - Type XIV: P5147, Sigma-Aldrich, ST Louis, MO USA) for one hour followed by 0.025% collagenase (from Clostridium histolyticum type 1A: C2674, Sigma-Aldrich) for 18 hours at room temperature. To remove remaining cell clusters, additional digestion with Cell dissociation solution, non-enzymatic 1 × (C1419, Sigma-Aldrich) was performed for two hours. Cells were then rinsed in 0.15 M NaCl and encapsulated in beads at a density of 2 × 106 cells/ml of 1.2% low viscosity alginate (Sigma-Aldrich). Beads were cultured in 12-well plates at a density of 10 beads/well with 2 ml of media (low glucose DMEM, 1% Pen/Strep, 0.5% Fungizone and 1% insulin-transferrin-selenium (ITS) (I2771, Sigma Aldrich)) for four days in hypoxia (5% O2, 5% CO2, 37°C).
For generation of CM from notochordal cells in tissue (NCT), the NP of three porcine discs (wet weight approximately 0.9 to 1.3 g) were soaked per 30 mls of low glucose DMEM, 0.5% Fungizone and 1% Pen/Strep without ITS for four days in hypoxia. Media was retained and filtered through a 70 um cell strainer (Thermo Fisher Scientific, Pittsburg, PA USA) to remove any remaining tissue.
NCA and NCT were both filtered through MW 3000 Amicon Ultra-15 (Millipore Bedford, MA USA) and re-suspended in 15 ml Basal media (B) (low glucose DMEM + 1% Pen/Strep + 1% ITS) in order to remove small metabolites and waste products. 15 ml of either NCT or NCA was added to each Amicon Ultra-15 filter and material on top (the concentrate) was resuspended in 15 ml Basal media with a final concentration of 1 ×. To verify the conditioned media used was the same from each notochordal culture all media was pooled for NCT and NCA respectively.
Pelleting of MSCs
Human bone marrow derived MSCs samples (age range 22 to 37 years, n = 3) were purchased from Texas A&M (Temple, TX, USA) with the appropriate Material Transfer Agreement and expanded in monolayer culture in alpha MEM medium supplemented with 10% fetal bovine serum. At passage 4, cells were pelleted at a density of 250,000 cells in 15 ml polypropylene tubes by centrifugation at 600 g for five minutes. They were then cultured in 500 μl of Chondrogenic media (C) (Basal media with 50 μg/ml ascorbate, 0.1 μM dexamethasone, 40 μg L-proline and 10 ng/ml TGFβ-3) in hypoxic conditions for 24 hours.
Treatment of MSCs with 4 CM types: B, NCT, NCA, and C
Study design for treatment of MSCs with B, C, NCA and NCT groups
Number of human samples
Time in culture
Number of pellets per sample
Alcian blue stain
Each pellet was lysed with 300 μl RNeasy Lysis RLT buffer (Qiagen: 79216 Valencia, CA USA) and the lysates from five pellets pooled stored at -80°C. RNA was extracted, cDNA synthesized and custom RT2 Profiler' SYBR green PCR arrays (SABiosciences: CAPH-0817A (Qiagen), Frederick, MA USA) were run by the Vermont Cancer Centre DNA analysis facility. The custom array included 42 genes associated with NP cell function: Phenotypic marker/Matrix-associated protein genes, growth factor genes, catabolic/anti-catabolic genes and inflammatory/pain genes (Additional file 1 Table S1 and Additional file 2 Table S2). Relative gene expression was calculated using the comparative Ct method normalized to undifferentiated MSCs from the same patients (Day 0) and three housekeeping genes (18s, GAPDH and β-actin). For normalization purposes, undetermined values for Day 0 were given an arbitrary value of 40 as undifferentiated MSCs did not express all the genes (leading to some catabolic genes with artificially high fold increases). Error bars were plotted as SEMs.
Glycosaminoglycan (GAG) and DNA content
To examine GAG and DNA in the cell pellet, spent media was removed and 200 μl of lysis buffer (Sigma Aldrich: L-8285; RNT70) was added to each cell pellet. This lysis buffer is routinely used to lyse cell membranes for the release of RNA/DNA and was also used to dissociate GAG associated with the cell pellet. The lysate was then assessed using the Di-methyl methylene Blue (DMMB) assay and the standard curve was generated in the lysis buffer used to dissociate the cell pellets. DMMB was then normalized to DNA content using the picogreen assay (Invitrogen, Carlsbad, CA, USA). To quantify the GAG released to media, media samples from the pellets of each media group retained over 21 days were assessed and each GAG measurement subtracted from the respective Day 0 control media (NCA. NCT, C and B before addition to pellets) averaged for the total 21 days and then normalized to DNA content .
Viability was analysed with the Live/Dead Kit (Invitrogen). Briefly, media was removed and the pellets were washed with PBS. Each pellet was resuspended in 100 μl of a 2 μM Calcein AM/1 μM Ethidium Homodimer-2 (ETH-2) staining solution and the cell suspension placed onto a microscope slide. Cells were incubated in the dark at 37°C for 30 minutes. After incubation a cover-slip was placed on top of the suspension and cells were visualized at 20 ×. Excitation and emission for Calcein and ETH-2 were 494/517 nm and 528/617 nm respectively with Calcein staining the cytoplasm of live cells green and ETH-2 staining the nuclear envelope of dead cells red.
Histology of pellets
To visualize the intact pellet, pellets were first fixed in formalin and then incubated with 1% Alcian Blue in HCl for 30 minutes, followed by final fixation in 100% ethanol. Pellets were embedded in freezing medium and 20 μm sections cut using a cryotome. Sections were re-stained with 1% Alcian Blue in HCL for 30 minutes in order to ensure full penetration of the dye to assess proteoglycan quantity and location, and also 4',6-diamidino-2-phenylindole (DAPI, Roche Diagnostics, Mannheim, Germany) which stains the nuclei of cells (Ultraviolet filter), followed by a wash with PBS. Images were captured on an Olympus BX50 light microscope (Center Valley, PA USA) at 20 × magnification.
Mass spectrometry and data analysis
While the presence of significant amounts of albumin (present in the ITS solution) greatly reduced the signal to noise and may have masked several important proteins, distinct bands running at approximately 37 kDa and 140 kDa for the NCT and NCA groups were observed (Additional file 3 Figure S3). Gel regions corresponding to these molecular weights were excised from each of the three lanes and subjected to in-gel tryptic digestion. Coomasie-stained regions of the SDS-PAGE gel were diced into 1 mm cubes. Gel pieces were reduced, alkylated with iodoacetamide and subjected to in-gel digestion as described previously . Dried peptides were subjected to liquid chromatography tandem mass spectrometry in a linear ion trap (LTQ) mass spectrometer (Thermo Electron Corporation Waltham, MA USA). Data were searched against the International Protein Index (IPI) non-redundant protein database using Sequest; requiring tryptic specificity; allowing precursor m/z tolerances of 2 Da; allowing methionine residues to be oxidized (+15.99 Da); and requiring cysteine residues to be carbamidomethylated (+57.02 Da). Peptides were filtered initially by requiring a XCorr value > 2 for doubly-charged peptides and > 2.5 for triply-charged peptides. Proteins having more than three peptides meeting these criteria were retained and XCorr values were then relaxed for peptides from these proteins to > 1.7 for doubly-charged peptides and > 2 for triply-charged peptides. Proteins that were common to unconditioned and conditioned media were discarded as well as proteins that did not have at least two porcine-specific peptides or had peptide that were not consistent with porcine origin as determined by the SEQUEST search analysis and manual BLAST analysis of each remaining peptide. To estimate the peptide false-discovery rate for the peptides identified in this study, we employed a statistical method using a target-decoy strategy as described in detail previously  As the complete porcine proteome is not available, and as the IPI indexed non-redundant database is not formatted for the generation of a decoy database, we searched all MS data against a concatenated forward (target) and reverse (decoy) IPI human protein database containing the sequences of the proteins harboring the porcine-specific proteins identified in this study. Using the same filtering criteria used for the non-redundant database search, we filtered the data to a false discovery rate of less than 0.01% at the peptide level. The proteins harboring porcine-specific peptides were again identified and remained in this dataset after filtering. Thus, the odds that any one of the identified peptides from these proteins is a false positive are less than 0.01%.
For qRT-PCR, statistical analysis was performed first by testing for normality using a Ryan-joiners test. For samples that were either parametric or non-parametric, a one sample t-test or one sample sign rank test of the ΔΔCt values with hypothesized value of 0 were carried out respectively (ΔΔCt for B, C, NCA and NCT groups and ΔΔCt = 0 for undifferentiated MSCs at Day 0/or B). GAG was assessed for normality and a one-way ANOVA with a Fisher's PLSD was done in order to check for significance between all media treatment groups (with P < 0.05 significant). Similar analysis using a one-way ANOVA with a Fisher's PLSD was carried out for DNA content. For a description of the statistical approach used in the proteomic analysis see the mass spectrometry and data analysis section above.
Gene expression data (significance > 2-fold normalized to Day 0 and B)
Gene expression data was normalized to Day 0 undifferentiated MSCs and also to B conditioned MSCs because of similarities between B and C groups. Only gene expression data with significance greater than two fold was discussed.
Phenotypic marker genes
Fold changes in gene expression data for media conditions B, C, NCA and NCT Significance greater than two-fold relative to Day 0 MSCs or Basal in bold and underlined; + = fold increase & - = fold decrease (P < 0
Normalized to Day 0
Normalized to Basal
Matrix-associated protein genes
B showed a significant increase in COL3A1 gene expression and decreases in ACAN and HAS1 expression relative to Day 0 (Table 2; Figure 1A). C demonstrated significant increases COL10A1 and COL3A1 relative to Day 0. However NCA showed significant decreases in COL1A1 and COL3A1 gene expression relative to Day 0 and B. NCT significantly increased COL2A1 and COL10A1 gene expression relative to Day 0 and B (Figure 1A).
A general up-regulation in the expression of catabolic enzymes was observed for all media groups post culture. B showed significant increases in ADAMTS4, MMP1, -13, -14 and -2 relative to Day 0 (Table 2; Figure 1B). C demonstrated significant increases in MMP13, -14, and -9 relative to Day 0. NCA showed significant increases in MMP14 and -9 relative to Day 0, and MMP1,-2, and -3 relative to Day 0 and B. NCT demonstrated significant increases in MMP14, -3 and -9 relative to Day 0 and ADAMTS4, MMP1 and -13 relative to Day 0 and B. Of the anti-catabolic proteins assessed, only TIMP1 showed significant increases in gene expression for B, NCA, and NCT relative to Day 0 (Table 2; Figure 1B).
Growth factor genes
In B, relative to Day 0, gene expression of TGFB3 and IGF was significantly up regulated and CTGF and EGF were significant down regulated (Table 2 Figure 1C). A significant decrease in CTGF expression relative to Day 0 and B was observed for C. NCA showed a significant increase in TGFB1 expression relative to Day 0 and decreases in TGFB2 and CTGF expression relative to Day 0 and B. NCT demonstrated significant increases in a number of growth factors; TGFB1 relative to Day 0 and B, and TGFB3 relative to Day 0 only including a significant down regulation in CTGF expression relative to Day 0.
B showed a significant decrease in BDNF expression relative to Day 0 (Table 2). C demonstrated no significant changes relative to Day 0 or B. In NCA a significant up-regulation of IL-1B relative to Day 0 was observed and TNFα was increased relative to both Day 0 and B. NCT also demonstrated a significant up-regulation of IL1B, however unlike NCA it down-regulated NGF relative to Day 0.
The majority of cells appeared alive and healthy (stained green) with very few dead cells (stained red) after three weeks culture (data not shown). There are no differences in cell viability between media groups. This suggests that despite all media conditions demonstrating some catabolic/inflammatory effects they did not induce cell death.
GAG and DNA content
Histology of pellets
Proteomics of media groups
Porcine-specific proteins/peptides identified via proteomic analysis of NCA
Porcine Protein and Peptides Identified
Identical in Bovine Ortholog
Redundancy in Database
alpha-2-macroglobulin precursor (163 kDa)
tenascin precursor (191 kDa)
clusterin precursor (52 kDa)
Human MSCs are a potential cell source for regeneration of the degenerated human IVD yet the appropriate method for pre-differentiation remains unclear. This study differentiated human MSCs for 21 days, using two notochordal cell media conditions as well as chondrogenic and basal media groups. The lack of clear NP phenotypic markers led to examination of a number of outcome measures including use of gene profiling with a custom PCR array of 42 genes associated with a healthy NP phenotype, an important innovation of this study, as well as assessments of GAG, histology, and cell viability. Culture of human MSCs in NCT stimulated anabolic changes most similar to a healthy NP phenotype rather than a chondrogenic phenotype with increased proteoglycan, while NCA conditioning resulted in significant down-regulation of fibrotic genes and minimal effects on the hypertrophic gene COLX. Chondrogenic and basal groups demonstrated many similarities in gene expression compared to Day 0 (pre-culture) conditions, suggesting that micromass culture under hypoxic conditions produces a similar gene profile as MSCs cultured with Chondrogenic media.
NCT conditioning of MSCs resulted in up-regulation of SOX9, COL2, and TGFB3 that could be associated with a healthy NP phenotype [10, 27, 28]. This was corroborated at the protein level with a significant increase in GAG associated with the cell pellet as shown by the DMMB assay and Alcian blue staining despite a decrease in ACAN at the gene level. The increase in GAGB observed for NCT relative to other media groups suggests that the cell phenotype induced with NCT was more closely an NP than chondrocytic phenotype. NCT also demonstrated an increase in matrix enzymes and IL-1B. However, because significant increases in most anabolic genes and GAG were also observed, it is possible that the catabolic effects induced by NCT are associated with remodeling during differentiation rather than a catabolic cell phenotype .
NCA had an anti-fibrotic effect on MSC differentiation with significant down-regulation of COL1A1 and COL3A1. Whilst significant increases were observed in COLX for both NCT and C, for NCA minimal changes in the hypertrophic marker COLX were noted. A common problem of in vitro induced chondrogenesis is hypertrophic differentiation of MSCS with increased expression of Collagen × [29, 42]. Hypertrophic differentiation and calcification has also been shown during intervertebral disc degeneration . Minimal changes in COLX expression suggests that NC cells in alginate alone may produce soluble factors capable of limiting or preventing hypertrophy and inhibiting synthesis of certain fibrous proteins. Unlike NCT, NCA had little impact on anabolic gene expression however accumulation of GAG was observed in MSCs after 21 days. These results are in contrast to a previous study that used conditioned media from NCs in alginate constructs to treat human MSCs for seven days and found increases in expression of matrix proteins . We can speculate that differences in gene expression may be due to the different time courses of the studies (7 days versus 21 days) or the differences in methods of CM generation.
A preliminary proteomics study demonstrated that NCA media conditions contained porcine alpha-2-macroglobulin, clusterin and tenascin. Intriguingly, these proteins have been implicated as cytoactive proteins that could be involved in reducing fibrous collagens, limiting matrix degradation or hypertrophy. Alpha-2-macroglobulin is an endoproteinase inhibitor present in blood and joint fluid which functions as a substrate for matrix enzymes such as ADAMTS-4 and -5 and inhibits their activity . Clusterin is known to be a multifunctional, secreted glycoprotein expressed in diverse locations, implicated in regulating complement activation and cell death in injured and degenerating tissues, and may have a cytoprotective effect on chondrocytes including NP cells [45, 46]. Tenascin is an extracellular matrix glycoprotein known to be abundant in the annulus of young IVDs and localized pericellularly in degenerated IVDs, and possibly could have a role in fibronectin - disc cell interactions . The biological roles of these proteins were not tested in this study, therefore, their effects are speculative and require further validation to confirm such roles.
Effects observed for C were consistent with the chondrocyte cell phenotype (a trend of increasing SOX9 and COL2 expression) at the gene and also at the protein level with GAG detected in the cell pellet. Results for B showed many similarities to that of C including the presence of GAG in the cell pellet. The only principal differences were a lack of COL2 expression and up-regulation of the phenotypic marker GPC1, growth factor TGFB3, and anti-catabolic protein TIMP1. These changes were unexpected as B was a control group. This suggests that the initial dose of TGFβ-3 for 24 hours followed by 3D culture/hypoxia for three weeks was sufficient to differentiate MSCs toward a chondrogenic phenotype. As a consequence of these unexpected findings, relative gene expression was normalized to Day 0, undifferentiated human MSCs, rather than B when examining the effects of NCA and NCT. Consequently, certain genes (that is, catabolic) were expressed at extremely low levels at Day 0 and relative expression levels are at very high orders of magnitude for all groups.
Until very recently no definitive markers of the IVD or NP cell phenotype were available, therefore markers of the chondrocyte phenotype were often used to assess MSC differentiation (for example, SOX9) [9, 27]. Microarray analysis of rat, bovine and canine IVD tissue has identified several candidate phenotypic markers such as Glypican, Biglycan, Keratin 19 and Laminin B1 [22, 23]. However, studies have also shown that species differences and degree of degeneration can influence the magnitude of expression of these genes, questioning their suitability as IVD/NP phenotypic markers [24, 25]. In this study, little change at the gene expression level was observed for these markers. Optimal NP phenotypic markers are a moving target as research continues to advance, and recent studies identified up to 12 NP positive and 36 negative marker genes using microarray analysis of human IVD cells, a subset of which were then examined in differentiated human MSCs . Future studies, therefore, require investigation of such markers to accurately assess differentiation of MSCs toward an NP phenotype.
The enhanced production of GAG in the NCT group suggests that NCs in their native tissue environment were able to differentiate MSCs toward an NP phenotype. At the gene level a decrease in aggrecan expression was noted however as protein data (GAG in pellets and histology) confirmed the presence of proteoglycan it is speculated that this effect may correspond to a negative feedback loop; as aggrecan has been made the cells down-regulate its gene expression, or alternately to the accumulation of GAG without production of aggrecan core protein. The increased GAG content is likely associated with greater total accumulation of GAG (as observed histologically with no differences in cell viability per group) as well as increased GAG per cell. The notochordal rich ECM is likely to influence the proteins present in the notochordal conditioned media from tissue and could be responsible for the observed effects on MSCs for this media group. Indeed the observed effects are likely a consequence of either soluble factors produced by NCs only when they are situated in their native matrix or factors derived from the matrix itself (for example, matricellular proteins). Although the SDS-PAGE and proteomic analysis of the NCT conditioned did not reveal observable differences in specific growth and differentiation factors, due largely to the masking effect of the bovine serum albumin in the samples, previous studies suggest many candidates. For example, the matricellular protein CTGF (connective tissue growth factor) has been implicated as an anabolic factor responsible for the effects mediated by NCCM on IVD biosynthesis . In this study, we observed significant down-regulation of CTGF at the gene level for all media groups. We suggest that this decrease in CTGF may represent a negative feed-back mechanism in which CTGF may have been synthesized at the beginning of culture or been present at sufficient levels in the CM.
This study used an in vitro micromass culture system with human MSCs and porcine notochordal derived conditioned media for differentiation toward a healthy NP phenotype. This cross-species comparison was justified as human BM-MSCs are currently the most clinically relevant cell source for disc repair and porcine notochordal cells unlike human notochordal cells are readily available; however, it cannot be ruled out that species differences may have had an impact on the results obtained and is, therefore, a limitation of the study. Our goal is to use the NC conditioned media to identify proteins as therapeutic agents and not to ultimately use porcine tissue to generate the therapeutic agent. Thus, this is solely an experimental model and there would not be a cross-species concern if this approach were ultimately used clinically. Proteoglycan measurements using both the DMMB assay and histological analyses using Alcian blue demonstrated similar trends adding confidence to both measurements; however, the presence of guanidine thiocyanate in the cell pellet lysis solution may interfere with the DMMB assay and could have an effect on total GAG content . The relatively small sample size can also be considered a limitation however trends were consistent between specimens and only significant changes were discussed here. NCA and NCT demonstrated differing effects on MSC differentiation at the gene and protein level and differences may be accounted for by the native cell-matrix interactions present in NCT compared to NCA with cells cultured alone. Alternatively cell extraction for the NCA group may have affected notochordal cell phenotype therefore gene profiling pre and post conditioning would be a necessary next step to determine this. NCA and NCT also demonstrated differences with regard to proteomic analysis with proteins identified in NCA only. This could be explained by the presence of BSA in the media masking larger matricellular proteins derived from native notochordal tissue and also the different cell-matrix environment as mentioned above. These lines of inquiry as well as proteomic analysis of albumin-free conditioned media will be the subject of future studies.
Using a custom PCR array of 42 genes associated with the healthy NP cell phenotype we have shown that CM derived from NCs had diverse effects on MSC differentiation toward a NP phenotype and this was dependent on the conditions in which the CM was generated. In their native IVD matrix NCs enhanced MSC differentiation toward an NP phenotype with increased production of GAG whilst CM derived from NCs alone cultured in alginate inhibited fibrotic genes and induced minimal effects on hypertrophic gene expression compared to standard chondrogenic media containing TGFβ-3. This was confirmed by histology and analysis of GAG in pellets. Likely candidates for the observed effects include anabolic matricellular proteins derived from the NC matrix itself. However, CM from NCs alone in alginate warrants further investigation due to the inhibitory effects observed on fibrotic genes and minimal effects on hypertrophic matrix proteins, of which clusterin and tenascin are possible candidate proteins identified in this study which require further validation. The development of an optimal method to pre-condition MSCs for injection into a degenerated IVD depends on our ability to successfully combine multiple factors. In addition to correctly formulated media, appropriate culture conditions will include proper MSC microenvironment (cell-cell/cell-matrix), and oxygen tension and mechanical stimulus. Once this has been realized, a therapy in which MSCs can restore the health of a degenerated IVD may be possible.
A distintegrin and metalloproteinase with thrombospondin motifs
connective tissue growth factor
Di-methyl methylene Blue
- IL-1 β:
Liquid Chromatography tandem mass spectrometry
mesenchymal stem cells
notochordal cells in alginate
conditioned medium derived from NCs
notochordal cells in tissue
Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis
transforming growth factor beta 3
tumor necrosis factor alpha.
This work supported by grants from the NIH (R21AR056037), the AO Research Fund (project F-09-10I) of the AO Foundation, and the Vermont Genetics Network through NIH grant P20 RR16462 from the INBRE Program of the NCRR (B.A.B.). We gratefully acknowledge technical assistance of Tim Hunter and Mary Lou Shane at the Vermont Cancer Center DNA Analysis Facility and Bin Deng at the Vermont Genetics Network Proteomics Core facility.
- Sakai D: Future perspectives of cell-based therapy for intervertebral disc disease. Eur Spine J. 2008, 17 (Suppl 4): 452-458.View ArticleGoogle Scholar
- Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ, Hoyland JA: Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem Soc Trans. 2007, 35: 652-655. 10.1042/BST0350652.View ArticleGoogle Scholar
- Le Maitre CL, Freemont AJ, Hoyland JA: Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther. 2007, 9: R45-10.1186/ar2198.View ArticleGoogle Scholar
- Le Maitre CL, Freemont AJ, Hoyland JA: The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther. 2005, 7: R732-745. 10.1186/ar1732.View ArticleGoogle Scholar
- Purmessur D, Freemont AJ, Hoyland JA: Expression and regulation of neurotrophins in the non-degenerate and degenerate human intervertebral disc. Arthritis Res Ther. 2008, 10: R99-10.1186/ar2487.View ArticleGoogle Scholar
- Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR: Multilineage potential of adult human mesenchymal stem cells. Science. 1999, 284: 143-147. 10.1126/science.284.5411.143.View ArticleGoogle Scholar
- Wuertz K, Godburn K, Neidlinger-Wilke C, Urban J, Iatridis JC: Behavior of mesenchymal stem cells in the chemical microenvironment of the intervertebral disc. Spine (Phila Pa 1976). 2008, 33: 1843-1849. 10.1097/BRS.0b013e31817b8f53.View ArticleGoogle Scholar
- Wuertz K, Godburn K, Iatridis JC: MSC response to pH levels found in degenerating intervertebral discs. Biochem Biophys Res Commun. 2009, 379: 824-829. 10.1016/j.bbrc.2008.12.145.View ArticleGoogle Scholar
- Mwale F, Roughley P, Antoniou J: Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. Eur Cell Mater. 2004, 8: 58-63. discussion 63-54Google Scholar
- Steck E, Bertram H, Abel R, Chen B, Winter A, Richter W: Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem Cells. 2005, 23: 403-411. 10.1634/stemcells.2004-0107.View ArticleGoogle Scholar
- Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takakura Y: Disc regeneration therapy using marrow mesenchymal cell transplantation: a report of two case studies. Spine (Phila Pa 1976). 2010, 35: E475-480.Google Scholar
- Watanabe T, Sakai D, Yamamoto Y, Iwashina T, Serigano K, Tamura F, Mochida J: Human nucleus pulposus cells significantly enhanced biological properties in a coculture system with direct cell-to-cell contact with autologous mesenchymal stem cells. J Orthop Res. 2010, 28: 623-630.Google Scholar
- Sakai D, Mochida J, Yamamoto Y, Nomura T, Okuma M, Nishimura K, Nakai T, Ando K, Hotta T: Transplantation of mesenchymal stem cells embedded in Atelocollagen gel to the intervertebral disc: a potential therapeutic model for disc degeneration. Biomaterials. 2003, 24: 3531-3541. 10.1016/S0142-9612(03)00222-9.View ArticleGoogle Scholar
- Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, Hotta T: Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration. Spine (Phila Pa 1976). 2005, 30: 2379-2387. 10.1097/01.brs.0000184365.28481.e3.View ArticleGoogle Scholar
- Risbud MV, Albert TJ, Guttapalli A, Vresilovic EJ, Hillibrand AS, Vaccaro AR, Shapiro IM: Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy. Spine. 2004, 29: 2627-2632. 10.1097/01.brs.0000146462.92171.7f.View ArticleGoogle Scholar
- Sobajima S, Vadala G, Shimer A, Kim JS, Gilbertson LG, Kang JD: Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J. 2008, 8: 888-896. 10.1016/j.spinee.2007.09.011.View ArticleGoogle Scholar
- Le Maitre CL, Baird P, Freemont AJ, Hoyland JA: An in vitro study investigating the survival and phenotype of mesenchymal stem cells following injection into nucleus pulposus tissue. Arthritis Res Ther. 2009, 11: R20-10.1186/ar2611.View ArticleGoogle Scholar
- Richardson SM, Walker RV, Parker S, Rhodes NP, Hunt JA, Freemont AJ, Hoyland JA: Intervertebral disc cell-mediated mesenchymal stem cell differentiation. Stem Cells. 2006, 24: 707-716. 10.1634/stemcells.2005-0205.View ArticleGoogle Scholar
- Le Visage C, Kim SW, Tateno K, Sieber AN, Kostuik JP, Leong KW: Interaction of human mesenchymal stem cells with disc cells: changes in extracellular matrix biosynthesis. Spine. 2006, 31: 2036-2042. 10.1097/01.brs.0000231442.05245.87.View ArticleGoogle Scholar
- Yang SH, Wu CC, Shih TT, Sun YH, Lin FH: In vitro study on interaction between human nucleus pulposus cells and mesenchymal stem cells through paracrine stimulation. Spine (Phila Pa 1976). 2008, 33: 1951-1957. 10.1097/BRS.0b013e31817e6974.View ArticleGoogle Scholar
- Richardson SM, Hoyland JA, Mobasheri R, Csaki C, Shakibaei M, Mobasheri A: Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol. 2010, 222: 23-32. 10.1002/jcp.21915.View ArticleGoogle Scholar
- Lee CR, Sakai D, Nakai T, Toyama K, Mochida J, Alini M, Grad S: A phenotypic comparison of intervertebral disc and articular cartilage cells in the rat. Eur Spine J. 2007, 16: 2174-2185. 10.1007/s00586-007-0475-y.View ArticleGoogle Scholar
- Rutges J, Creemers LB, Dhert W, Milz S, Sakai D, Mochida J, Alini M, Grad S: Variations in gene and protein expression in human nucleus pulposus in comparison with annulus fibrosus and cartilage cells: potential associations with aging and degeneration. Osteoarthritis Cartilage. 18: 416-423.
- Gilson A, Dreger M, Urban JP: Differential expression level of cytokeratin 8 in cells of the bovine nucleus pulposus complicates the search for specific intervertebral disc cell markers. Arthritis Res Ther. 2010, 12: R24-10.1186/ar2931.View ArticleGoogle Scholar
- Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA: Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes. Arthritis Res Ther. 2010, 12: R22-10.1186/ar2929.View ArticleGoogle Scholar
- Minogue BM, Richardson SM, Zeef LA, Freemont AJ, Hoyland JA: Characteriation of the human nucleus pulposus cell phenotype and evaluation of novel marker gene expression to define adult stem cell differentiation. Arthritis Rheum. 2010, 62: 3695-3705. 10.1002/art.27710.View ArticleGoogle Scholar
- Sive JI, Baird P, Jeziorsk M, Watkins A, Hoyland JA, Freemont AJ: Expression of chondrocyte markers by cells of normal and degenerate intervertebral discs. Mol Pathol. 2002, 55: 91-97. 10.1136/mp.55.2.91.View ArticleGoogle Scholar
- Risbud MV, Di Martino A, Guttapalli A, Seghatoleslami R, Denaro V, Vaccaro AR, Albert TJ, Shapiro IM: Toward an optimum system for intervertebral disc organ culture: TGF-beta 3 enhances nucleus pulposus and anulus fibrosus survival and function through modulation of TGF-beta-R expression and ERK signaling. Spine. 2006, 31: 884-890. 10.1097/01.brs.0000209335.57767.b5.View ArticleGoogle Scholar
- Mwale F, Girard-Lauriault PL, Wang HT, Lerouge S, Antoniou J, Wertheimer MR: Suppression of genes related to hypertrophy and osteogenesis in committed human mesenchymal stem cells cultured on novel nitrogen-rich plasma polymer coatings. Tissue Eng. 2006, 12: 2639-2647. 10.1089/ten.2006.12.2639.View ArticleGoogle Scholar
- Seguin CA, Pilliar RM, Roughley PJ, Kandel RA: Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine. 2005, 30: 1940-1948. 10.1097/01.brs.0000176188.40263.f9.View ArticleGoogle Scholar
- Walmsley R: The development and growth of the intervertebral disc. Edinb Med J. 1953, 60: 341-364.Google Scholar
- Korecki CL, Taboas JM, Tuan RS, Iatridis JC: Notochordal cell conditioned medium stimulates mesenchymal stem cell differentiation toward a young nucleus pulposus phenotype. Stem Cell Res Ther. 2010, 1: 18-10.1186/scrt18.View ArticleGoogle Scholar
- Roughley PJ: Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine. 2004, 29: 2691-2699. 10.1097/01.brs.0000146101.53784.b1.View ArticleGoogle Scholar
- Erwin WM, Inman RD: Notochord cells regulate intervertebral disc chondrocyte proteoglycan production and cell proliferation. Spine. 2006, 31: 1094-1099. 10.1097/01.brs.0000216593.97157.dd.View ArticleGoogle Scholar
- Aguiar DJ, Johnson SL, Oegema TR: Notochordal cells interact with nucleus pulposus cells: regulation of proteoglycan synthesis. Exp Cell Res. 1999, 246: 129-137. 10.1006/excr.1998.4287.View ArticleGoogle Scholar
- Chen J, Yan W, Setton LA: Molecular phenotypes of notochordal cells purified from immature nucleus pulposus. Eur Spine J. 2006, 15 Suppl 15: 303-311.View ArticleGoogle Scholar
- Guehring T, Wilde G, Sumner M, Grunhagen T, Karney GB, Tirlapur UK, Urban JP: Notochordal intervertebral disc cells: sensitivity to nutrient deprivation. Arthritis Rheum. 2009, 60: 1026-1034. 10.1002/art.24407.View ArticleGoogle Scholar
- Farndale RW, Buttle DJ, Barrett AJ: Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 1986, 883: 173-177.View ArticleGoogle Scholar
- Zappaterra MD, Lisgo SN, Lindsay S, Gygi SP, Walsh CA, Ballif BA: A comparative proteomic analysis of human and rat embryonic cerebrospinal fluid. J Proteome Res. 2007, 6: 3537-3548. 10.1021/pr070247w.View ArticleGoogle Scholar
- Elias JE, Gygi SP: Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007, 4: 207-214. 10.1038/nmeth1019.View ArticleGoogle Scholar
- Bertram H, Boeuf S, Wachters J, Boehmer S, Heisel C, Hofmann MW, Piecha D, Richter W: Matrix metalloprotease inhibitors suppress initiation and progression of chondrogenic differentiation of mesenchymal stromal cells in vitro. Stem Cells Dev. 2009, 18: 881-892. 10.1089/scd.2008.0306.View ArticleGoogle Scholar
- Weiss S, Hennig T, Bock R, Steck E, Richter W: Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells. J Cell Physiol. 2010, 223: 84-93.Google Scholar
- Rutges JP, Duit RA, Kummer JA, Oner FC, van Rijen MH, Verbout AJ, Castelein RM, Dhert WJ, Creemers LB: Hypertrophic differentiation and calcification during intervertebral disc degeneration. Osteoarthritis Cartilage. 2010, 18: 1487-1495. 10.1016/j.joca.2010.08.006.View ArticleGoogle Scholar
- Tortorella MD, Arner EC, Hills R, Easton A, Korte-Sarfaty J, Fok K, Wittwer AJ, Liu RQ, Malfait AM: Alpha2-macroglobulin is a novel substrate for ADAMTS-4 and ADAMTS-5 and represents an endogenous inhibitor of these enzymes. J Biol Chem. 2004, 279: 17554-17561. 10.1074/jbc.M313041200.View ArticleGoogle Scholar
- Connor JR, Kumar S, Sathe G, Mooney J, O'Brien SP, Mui P, Murdock PR, Gowen M, Lark MW: Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthritis Cartilage. 2001, 9: 727-737. 10.1053/joca.2001.0475.View ArticleGoogle Scholar
- Khan IM, Salter DM, Bayliss MT, Thomson BM, Archer CW: Expression of clusterin in the superficial zone of bovine articular cartilage. Arthritis Rheum. 2001, 44: 1795-1799. 10.1002/1529-0131(200108)44:8<1795::AID-ART316>3.0.CO;2-K.View ArticleGoogle Scholar
- Gruber HE, Ingram JA, Hanley EN: Tenascin in the human intervertebral disc: alterations with aging and disc degeneration. Biotech Histochem. 2002, 77: 37-41.View ArticleGoogle Scholar
- Erwin WM, Ashman K, O'Donnel P, Inman RD: Nucleus pulposus notochord cells secrete connective tissue growth factor and Up-regulate proteoglycan expression by intervertebral disc chondrocytes. Arthritis Rheum. 2006, 54: 3859-3867. 10.1002/art.22258.View ArticleGoogle Scholar
- Hoemann CD, Sun J, Chrzanowski V, Buschmann MD: A multivalent assay to detect glycosaminoglycan, protein, collagen, RNA, and DNA content in milligram samples of cartilage or hydrogel-based repair cartilage. Anal Biochem. 2002, 300: 1-10. 10.1006/abio.2001.5436.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.